Literature DB >> 4133642

Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate.

S P Parbhoo, A Ajdukiewicz, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4133642     DOI： 10.1016/s0140-6736(74)91260-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Clinical experience with the Rhône-Poulenc ascites reinfusion apparatus.

Authors:  P J Moult; S P Parbhoo; S Sherlock
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

2.  Fulminant Wilson's disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens.

Authors:  A N Hamlyn; J L Gollan; A P Douglas; S Sherlock
Journal:  Br Med J       Date:  1977-09-10

Review 3.  Haemostatic problems in liver disease.

Authors:  D A Kelly; E G Tuddenham
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

4.  Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis.

Authors:  C Clemente; J Bosch; J Rodés; V Arroyo; A Mas; S Maragall
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

5.  Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.

Authors:  Rumi Hanada; Naosuke Yokomichi; Chihiro Kato; Kazumi Miki; Sachiko Oyama; Tatsuya Morita; Ryoko Kawahara
Journal:  Support Care Cancer       Date:  2017-11-22       Impact factor: 3.603

6.  Management of hepatic ascites.

Authors: 
Journal:  Br Med J       Date:  1978-01-14

7.  Ultrafiltration for intractable ascites after liver transplantation.

Authors:  G Noble-Jamieson; N Jamieson; N D Barnes
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

8.  Bizarre complications of peritoneovenous shunts.

Authors:  F E Eckhauser; W E Strodel; J W Girardy; J G Turcotte
Journal:  Ann Surg       Date:  1981-02       Impact factor: 12.969

9.  Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.

Authors:  Naosuke Yokomichi; Kengo Imai; Masaki Sakamoto; Masashi Horiki; Toshihiro Yamauchi; Satoru Miwa; Satoshi Inoue; Yu Uneno; Hidekazu Suzuki; Toru Wada; Yuri Ichikawa; Tatsuya Morita
Journal:  BMC Cancer       Date:  2022-02-28       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.